首页> 外国专利> Regulating apoptosis in TRAIL-resistant cancer cells, while protecting normal, non-cancerous cells

Regulating apoptosis in TRAIL-resistant cancer cells, while protecting normal, non-cancerous cells

机译:调节TRAIL耐药癌细胞的凋亡,同时保护正常的非癌细胞

摘要

Provided are compositions and methods for controlling, modulating or regulating extrinsically-induced apoptosis in a population of cells, comprising treating the cell population with a synergistically combined composition comprising an amount of TRAIL in conjunction with an amount of at least one reagent acting on mitochondrial pathways of the cells, which in combination is sufficient to induce cellular apoptosis, such that the apoptosis-inducing effect of the combination is greater than that of TRAIL alone, or the at least one reagent alone, or the additive individual apoptotic effects of TRAIL and the at least one reagent. However, TRAIL-sensitive normal cells are protected from the extrinsically induced apoptosis by treatment with a specific caspase inhibitor, such as a caspase 9 inhibitor. Consequently, in accordance with the present invention, TRAIL-resistant cancer cells are treated and killed with an apoptosis-inducing amount of the TRAIL combination, but the normal cells are protected or rescued from apoptosis by treatment with the specific caspase inhibitor.
机译:提供了用于控制,调节或调节细胞群中外源性诱导的凋亡的组合物和方法,包括用协同组合的组合物处理细胞群,所述组合物包含一定量的TRAIL和一定量的至少一种作用于线粒体途径的试剂。组合足以诱导细胞凋亡的细胞数,使得该组合的凋亡诱导作用大于单独的TRAIL或单独的至少一种试剂或单独的TRAIL和单独的TRAIL和单独的细胞凋亡作用。至少一种试剂。然而,通过用特定的胱天蛋白酶抑制剂,例如胱天蛋白酶9抑制剂处理,可以保护TRAIL敏感的正常细胞免受外源性诱导的凋亡。因此,根据本发明,用诱导凋亡的量的TRAIL组合治疗和杀死TRAIL抗性癌细胞,但是通过用特定的半胱天冬酶抑制剂处理可以保护或拯救正常细胞免于凋亡。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号